What Happened?
, -based XORTX Promoted James Fairbairn as Chief Financial Officer
About the Company
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
About the Person
James Fairbairn is Chief Financial Officer at XORTX. Previously, James held various senior HR leadership roles in the industry.
Info Source
News
Short Profile